← Eichor
Study identifier: NCT05903001 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Diaphragmatic Function as a Biomarker

Condition: Dyspnea; Asthmatic · COPD · Fibrosis  ·  Sponsor: RWTH Aachen University

PhaseN/A
Planned participants800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Dyspnea is among the most common symptoms in patients with respiratory diseases such as Asthma, chronic obstructive pulmonary disease (COPD), Fibrosis, and Pulmonary Hypertension. However, the pathophysiology and underlying mechanisms of dyspnea in patients with respiratory diseases are still poorly understood. Diaphragm dysfunction might be highly prevalent in patients with dyspnea and respiratory diseases. The association of diaphragm function and potential prognostic significance in patients with respiratory diseases has not yet been investigated.

This description comes directly from the study's public registry record.

Talk to the study team

Jens Spiesshoefer, MD  ·  0049 2418037036  ·  jspiesshoefer@ukaachen.de

Always discuss trial participation with your own doctor first.

Locations (1)

RWTH Aachen University HospitalAachen, North Rhine-Westphalia, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05903001